Cover Image
市場調查報告書

結核檢驗的全球市場 2014∼2020年:產業分析、規模、佔有率、成長、趨勢及預測

Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing & Other TB Tests) Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020

出版商 Transparency Market Research 商品編碼 328539
出版日期 內容資訊 英文 109 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
結核檢驗的全球市場 2014∼2020年:產業分析、規模、佔有率、成長、趨勢及預測 Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing & Other TB Tests) Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020
出版日期: 2015年03月23日 內容資訊: 英文 109 Pages
簡介

結核 (TB) 是傳染性高的疾病,人類型結核菌或 MTB感染為成因,主要感染人類的肺。很多患者患結核二種形式:活動性結核和潛伏性結核病。按照感染部位結核有肺結核 (肺) 、骨骼繫結核(骨、關節)、胸膜結核,淋巴節結核,消化器官結核,及結核性腦膜炎等幾個類型。 肺結核是傳染性最高疾病,給予全球許多人影響。

本報告提供全球結核檢驗市場相關調查、市場收益的實際成果、預測、市場促進要素、阻礙要素分析、各檢驗類型、地區的分析與預測、競爭情形,及主要企業簡介等彙整,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 全球結核檢驗市場概要

  • 簡介
  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 波特的五力分析
  • 價值鏈分析
  • 市場魅力度分析
  • 競爭情形

第4章 全球結核檢驗市場:各檢驗類型

  • 簡介
  • 污點顯微鏡
  • 培養型檢驗
  • 核酸檢驗
  • 結核菌素反應檢驗 (TST)
  • 放射線 (胸部X光掃描)
  • 藥物敏感性實驗 (DST)
  • 其他檢驗 (血清檢驗、IGRA、其他)

第5章 全球結核檢驗市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (ROW)

第6章 建議

  • 強調各種TB診斷檢驗的價格管制
  • 著重增加獲得政府投資以改善實驗室功能、基礎設施
  • 以亞太地區、其他 (ROW) 地區的新興市場為目標

第7章 企業簡介

  • Abbott Laboratories
  • Akonni Biosystems, Inc.
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cepheid
  • Epistem Holdings Plc
  • Hain Lifescience GmbH
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Sanofi
  • Thermo Fisher Scientific, Inc.
  • QIAGEN

圖表

目錄

This report on tuberculosis testing studies the current as well as future prospects of the market globally. Tuberculosis (TB) is a highly contagious disease, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. People majorly suffer from two forms of TB: active tuberculosis and latent tuberculosis. The several types of TB based on the site of infection are pulmonary TB (lungs), skeletal TB (bone and joints), pleural TB, lymph node TB, gastrointestinal TB, and TB meningitis. Pulmonary TB is the most contagious disease and affects a large number of individuals globally. Based on types of tests, the tuberculosis testing market has been segmented into seven major categories: smear microscopy, culture-based tests, nucleic acid testing, Mantoux test or tuberculin skin tests (TST), radiography (chest x-ray), drug susceptibility testing (DST) and other TB tests.

This report comprises an elaborate executive summary that includes a market snapshot that provides overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global tuberculosis testing market with respect to leading market segments based on types of tests as well as different geographic regions. The respective markets for the considered tuberculosis tests have been extensively analyzed on the basis of their usefulness, effectiveness, sales revenue and geographic presence. The market size and forecast in terms of USD million for each type of test has been provided for the period from 2012 to 2020. This report on tuberculosis testing market also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.

Geographically, the global tuberculosis testing market has been categorized into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The four major geographic markets have been further divided into seven sub-segments (major TB tests). The market size and forecast for each of these sub-segments have been provided for the period from 2012 to 2020, along with CAGR (%) for the forecast period from 2014 to 2020. The study also incorporates the competitive scenario in these regions.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global tuberculosis testing market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter's five forces analysis and key players' market share and product wise heat map analysis in 2013 for the global TB testing market.

A list of recommendations has been provided for new entrants as well as existing market players to help establish a strong presence in the market and increase their market share. The report also profiles major players in the tuberculosis testing market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic, QIAGEN, Sanofi and Thermo Fisher Scientific, Inc.

The global tuberculosis testing market is segmented as follows:

Tuberculosis Testing Market, by Test Type

  • Smear Microscopy
  • Culture Based Tests
  • Nucleic Acid Testing
  • Mantoux Test (Tuberculin Skin Test)
  • Radiography (Chest X-Ray)
  • Drug Susceptibility Testing (DST)
  • Other Tests (Serological Tests, IGRA, ADA, etc.)

Tuberculosis Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Tuberculosis Testing Market
  • 2.2 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Tuberculosis Testing Market Overview

  • 3.1 Introduction
    • 3.1.1 Epidemiology: Tuberculosis
    • 3.1.2 TB Incidence
    • 3.1.3 Diagnosis and Treatment
  • 3.2 Market Drivers
    • 3.2.1 Increased Acceptance of Various TB Testing Techniques due to High Prevalence and Incidence Rates of the Disease Globally
    • 3.2.2 Tuberculosis Awareness and Control Programs from Government and Non-Government Organizations Worldwide Likely to Fuel Growth in Demand for Various TB Tests
    • 3.2.3 Rising Demand for New, Improved, and Technologically Advanced Tuberculosis Testing Procedures and Equipment
  • 3.3 Market Restraints
    • 3.3.1 High Cost of Various Tuberculosis Tests may Affect the Overall Global Demand
  • 3.4 Market Opportunities
    • 3.4.1 Presence of a Huge Potential Market in Most of the Emerging Nations of the World
  • 3.5 Porter's Five Forces Analysis: Global Tuberculosis Testing Market
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of Substitutes
    • 3.5.4 Threat of New Entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Value Chain Analysis: Tuberculosis Testing Market
  • 3.7 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography
  • 3.8 Competitive Landscape
    • 3.8.1 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2013 (Value %)
    • 3.8.2 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players

Chapter 4 Global Tuberculosis Testing Market, by Test Type

  • 4.1 Introduction
    • 4.1.1 Global Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
    • 4.1.2 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2013 & 2020 (Value %)
  • 4.2 Smear Microscopy
    • 4.2.1 Global Smear Microscopy (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • 4.3 Culture Based Tests
    • 4.3.1 Global Culture Based Tests (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • 4.4 Nucleic Acid Testing
    • 4.4.1 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • 4.5 Mantoux Test (Tuberculin Skin Test (TST))
    • 4.5.1 Global Tuberculin Skin Tests Market Revenue, 2012 - 2020 (USD Million)
  • 4.6 Radiography (Chest X-Ray)
    • 4.6.1 Global Radiography (Chest X-Ray) Market Revenue, 2012 - 2020 (USD Million)
  • 4.7 Drug Susceptibility Testing (DST)
    • 4.7.1 Global Drug Susceptibility Testing Market Revenue, 2012 - 2020 (USD Million)
  • 4.8 Other Tests (Serological Tests, IGRA, etc.)
    • 4.8.1 Global Other TB Testing Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Global Tuberculosis Testing Market, by Geography

  • 5.1 Overview
    • 5.1.1 Global Tuberculosis Testing Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 5.2 North America
    • 5.2.1 North America Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.2.2 North America Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.3.2 Europe Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.4.2 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
    • 5.5.2 RoW Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)

Chapter 6 Recommendations

  • 6.1 Emphasize on Price Control of Various TB Diagnostic Tests
  • 6.2 Focus on Obtaining Increased Government Investments for the Improvement of Laboratory Capacities and Infrastructure
  • 6.3 Target Emerging Markets of Asia Pacific and RoW

Chapter 7 Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Akonni Biosystems, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 Alere, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 Becton, Dickinson and Company
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 bioMérieux SA
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent developments
  • 7.6 Cepheid
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Epistem Holdings Plc
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Developments
  • 7.8 Hain Lifescience GmbH
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments
  • 7.9 F. Hoffmann-La Roche Ltd.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Overview
    • 7.9.3 Product Portfolio
    • 7.9.4 Business Strategies
    • 7.9.5 Recent Developments
  • 7.10 Hologic, Inc.
    • 7.10.1 Company overview
    • 7.10.2 Financial Overview
    • 7.10.3 Product Portfolio
    • 7.10.4 Business Strategies
    • 7.10.5 Recent Developments
  • 7.11 Sanofi
    • 7.11.1 Company Overview
    • 7.11.2 Financial Overview
    • 7.11.3 Product Portfolio
    • 7.11.4 Business Strategies
    • 7.11.5 Recent Developments
  • 7.12 Thermo Fisher Scientific, Inc.
    • 7.12.1 Company Overview
    • 7.12.2 Financial Overview
    • 7.12.3 Product Portfolio
    • 7.12.4 Business Strategies
    • 7.12.5 Recent Developments
  • 7.13 QIAGEN
    • 7.13.1 Company Overview
    • 7.13.2 Financial Overview
    • 7.13.3 Product portfolio
    • 7.13.4 Business Strategies
    • 7.13.5 Recent Developments

List of Figures

  • FIG. 1 Tuberculosis Testing: Market Segmentation
  • FIG. 2 Global Tuberculosis Testing Market Revenue, by Test Type, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Tuberculosis Testing Market Revenue, by Geography, 2013 & 2020 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Tuberculosis Testing Market
  • FIG. 5 Value Chain Analysis: Global Tuberculosis Testing Market
  • FIG. 6 Market Attractiveness Analysis: Global Tuberculosis Testing Market, by Geography, 2013
  • FIG. 7 Market Share Analysis, by Key Players: Global Tuberculosis Testing Market, 2013 (Value %)
  • FIG. 8 Heat Map Analysis: Global Tuberculosis Testing Market, by Key Players
  • FIG. 9 Comparative Analysis: Global Tuberculosis Testing Market, by Test Type, 2013 & 2020 (Value %)
  • FIG. 10 Global Smear Microscopy (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Global Culture Based Tests (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 Global Nucleic Acid Testing (TB Testing) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 Global Tuberculin Skin Tests Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 Global Radiography (Chest X-Ray) Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Global Drug Susceptibility Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 Global Other TB Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 North America Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 Europe Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Asia Pacific Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 RoW Tuberculosis Testing Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Abbott Laboratories: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22 Alere, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 23 Becton, Dickinson and Company: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24 bioMérieux SA: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25 Cepheid: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26 Epistem Holdings Plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 28 Hologic, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 29 Sanofi: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 31 QIAGEN: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Tuberculosis Testing Market
  • TABLE 2 Global Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 3 Global Tuberculosis Testing Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 4 North America Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 5 Europe Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 6 Asia Pacific Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
  • TABLE 7 RoW Tuberculosis Testing Market Revenue, by Test Type, 2012 - 2020 (USD Million)
Back to Top